United States Biotechnology & Medical Research

Kiromic Biopharma Inc (KRBPQ)

Track

Track

Kiromic Biopharma Inc. experienced multiple insider trading transactions during August 2024. Executives, including the Chief Executive Officer and Chief Financial Officer, acquired shares through open market purchases. The most recent activity occurred on August 26, 2024. No further trades have been recorded within the last three months.
Ticker: KRBPQ Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kiromic Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.2
BERSANI PIETRO Chief Executive Officer Executive Director
Transaction date
Purchase
Price
267.82
Quantity 29,239 +31.0%
Value US$2,424,593
1.2
BERSANI PIETRO Chief Executive Officer Executive Director
Transaction date
Purchase
Price
15.52
Quantity 46,416 -37.6%
Value US$1,107,444
1.3
Hungerford Brian Chief Financial Officer Officer
Transaction date
Purchase
Price
382.29
Quantity 2,798 +27.7%
Value US$1,352,125
1.3
Hungerford Brian Chief Financial Officer Officer
Transaction date
Purchase
Price
2.25
Quantity 258 +0.4%
Value US$580
1.3
Hungerford Brian Chief Financial Officer Officer
Transaction date
Purchase
Price
1.75
Quantity 2,000 +3.4%
Value US$3,500
1.3
Hungerford Brian CFO Officer
Transaction date
Purchase
Price
2.60
Quantity 1,000 +1.7%
Value US$2,600
0.8
Misajon Pamela Non-Executive Director
Transaction date
Purchase
Price
3.24
Quantity 410 +1.4%
Value US$1,328
0.8
Misajon Pamela Non-Executive Director
Transaction date
Purchase
Price
3.30
Quantity 1,200 +4.4%
Value US$3,960
1.3
Hungerford Brian CFO Officer
Transaction date
Purchase
Price
3.18
Quantity 1,000 +1.8%
Value US$3,180
1.2
BERSANI PIETRO CEO Executive Director
Transaction date
Purchase
Price
3.28
Quantity 3,000 +2.2%
Value US$9,840
0.5
NAGEL MICHAEL Non-Executive Director
Transaction date
Purchase
Price
3.33
Quantity 1,000 +2.4%
Value US$3,330
1.2
BERSANI PIETRO CEO Executive Director
Transaction date
Purchase
Price
3.23
Quantity 3,000 +2.3%
Value US$9,690
0.8
Misajon Pamela Non-Executive Director
Transaction date
Purchase
Price
2.93
Quantity 1,701 +6.7%
Value US$4,984
2.9
Schneider Jerry A. Non-Executive Director
Transaction date
Purchase
Price
7.31
Quantity 5,000 +inf%
Value US$36,550
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-26 2024-08-26 B Purchase
1.2
BERSANI PIETRO

Chief Executive Officer

Executive Director
29,239 +31.0%
267.82
US$2,424,593 		29,239 +31.0% 267.82 US$2,424,593
2024-08-26 2024-08-23 B Purchase
1.2
BERSANI PIETRO

Chief Executive Officer

Executive Director
46,416 -37.6%
15.52
US$1,107,444 		46,416 -37.6% 15.52 US$1,107,444
2024-08-21 2024-08-20 B Purchase
1.3
Hungerford Brian

Chief Financial Officer

Officer
2,798 +27.7%
382.29
US$1,352,125 		2,798 +27.7% 382.29 US$1,352,125
2024-08-21 2024-08-19 B Purchase
1.3
Hungerford Brian

Chief Financial Officer

Officer
258 +0.4%
2.25
US$580 		258 +0.4% 2.25 US$580
2024-08-14 2024-08-13 B Purchase
1.3
Hungerford Brian

Chief Financial Officer

Officer
2,000 +3.4%
1.75
US$3,500 		2,000 +3.4% 1.75 US$3,500
2024-06-13 2024-06-13 B Purchase
1.3
Hungerford Brian

CFO

Officer
1,000 +1.7%
2.60
US$2,600 		1,000 +1.7% 2.60 US$2,600
2024-06-13 2024-06-12 B Purchase
0.8
Misajon Pamela
Non-Executive Director
410 +1.4%
3.24
US$1,328 		410 +1.4% 3.24 US$1,328
2024-06-13 2024-06-12 B Purchase
0.8
Misajon Pamela
Non-Executive Director
1,200 +4.4%
3.30
US$3,960 		1,200 +4.4% 3.30 US$3,960
2024-06-12 2024-06-12 B Purchase
1.3
Hungerford Brian

CFO

Officer
1,000 +1.8%
3.18
US$3,180 		1,000 +1.8% 3.18 US$3,180
2024-06-12 2024-06-12 B Purchase
1.2
BERSANI PIETRO

CEO

Executive Director
3,000 +2.2%
3.28
US$9,840 		3,000 +2.2% 3.28 US$9,840
2024-06-12 2024-06-11 B Purchase
0.5
NAGEL MICHAEL
Non-Executive Director
1,000 +2.4%
3.33
US$3,330 		1,000 +2.4% 3.33 US$3,330
2024-06-12 2024-06-11 B Purchase
1.2
BERSANI PIETRO

CEO

Executive Director
3,000 +2.3%
3.23
US$9,690 		3,000 +2.3% 3.23 US$9,690
2024-06-12 2024-06-10 B Purchase
0.8
Misajon Pamela
Non-Executive Director
1,701 +6.7%
2.93
US$4,984 		1,701 +6.7% 2.93 US$4,984
2021-05-26 2021-05-24 B Purchase
2.9
Schneider Jerry A.
Non-Executive Director
5,000 +inf%
7.31
US$36,550 		5,000 +inf% 7.31 US$36,550
Explore more

More insider trading research around Kiromic Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America